Published on 14 Feb 2024 on Zacks via Yahoo Finance
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $1.66 per share versus the Zacks Consensus Estimate of a loss of $1.46. This compares to earnings of $1.60 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -13.70%. A quarter ago, it was expected that this company would post a loss of $1.47 per share when it actually produced earnings of $8.46, delivering a surprise of 675.51%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.